On June 20, 2025, Viridian Therapeutics, Inc. held its Annual Meeting where stockholders approved key resolutions including an increase of 8 million shares in the 2016 Equity Incentive Plan and the election of directors, with 81.6 million shares outstanding as of April 22, 2025.